Favus Treatment & Management

  • Author: Jacek C Szepietowski, MD, PhD; Chief Editor: Dirk M Elston, MD   more...
 
Updated: Jan 23, 2012
 

Medical Care

Although favus is not highly contagious, several family members may be affected, and all should be treated simultaneously. Treatment outcome depends on the stage at which the disease is arrested. Severe long-lasting disease can cause irreversible scarring alopecia.

In most patients, favus involves hair; therefore, the disease requires systemic treatment. Additional topical agents, such as shampoo (2% ketoconazole, 2.5% selenium sulfide), lotion, and cream may be helpful. X-ray epilation no longer is used. General hygiene of the scalp must be improved, and debris and crusts must be removed.

Favus usually is controlled by griseofulvin, the standard treatment of tinea capitis; however, a longer treatment course than usual for tinea capitis may be advisable. Currently, favus is uncommon; therefore, no clinical trials with newer antifungals are available. In vitro studies indicate that Trichophyton schoenleinii is sensitive to newer antifungal drugs, similar to other dermatophytes. Terbinafine, itraconazole, and fluconazole in a similar dosage schedule to tinea capitis may eradicate the fungus and cure the disease.

Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Jacek C Szepietowski, MD, PhD  Professor, Vice-Head, Department of Dermatology, Venereology and Allergology, Wroclaw Medical University; Director of the Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Poland

Disclosure: Stiefel GSK Company Salary Employment; Orfagen Consulting fee Consulting; Maruho Consulting fee Consulting; Astellas Consulting fee Consulting; Abbott Consulting fee Consulting; Leo Pharma Consulting fee Consulting

Coauthor(s)

Robert A Schwartz, MD, MPH  Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, University of Medicine and Dentistry of New Jersey-New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi

Disclosure: Nothing to disclose.

Specialty Editor Board

Franklin Flowers, MD  Chief, Division of Dermatology, Professor, Department of Medicine and Otolaryngology, Affiliate Associate Professor of Pediatrics and Pathology, University of Florida College of Medicine

Franklin Flowers, MD, is a member of the following medical societies: American College of Mohs Micrographic Surgery and Cutaneous Oncology

Disclosure: Nothing to disclose.

Richard P Vinson, MD  Assistant Clinical Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine; Consulting Staff, Mountain View Dermatology, PA

Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Association of Military Dermatologists, Texas Dermatological Society, and Texas Medical Association

Disclosure: Nothing to disclose.

Paul Krusinski, MD  Director of Dermatology, Fletcher Allen Health Care; Professor, Department of Internal Medicine, University of Vermont College of Medicine

Paul Krusinski, MD is a member of the following medical societies: American Academy of Dermatology, American College of Physicians, and Society for Investigative Dermatology

Disclosure: Nothing to disclose.

Catherine M Quirk, MD  Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania

Catherine M Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD  Director, Ackerman Academy of Dermatopathology, New York

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of eMedicine gratefully acknowledge the contributions of previous Chief Editor, William D. James, MD, to the development and writing of this article.

References

  1. Cecchi R, Paoli S, Giomi A, Rossetti R. Favus due to Trichophyton schoenleinii in a patient with metastatic bronchial carcinoma. Br J Dermatol. May 2003;148(5):1057. [Medline].

  2. Khaled A, Ben Mbarek L, Kharfi M, et al. Tinea capitis favosa due to Trichophyton schoenleinii. Acta Dermatovenerol Alp Panonica Adriat. 2007;16:34-46.

  3. Raszeja-Kotelba B, Adamski Z, Pawlowicz A. A case of tinea favosa capitis caused by Trichophyton schoenleinii. Przegl Dermatol. 1993;80:518-24.

  4. Besbes M, Cheikhrouhou F, Sellami H, Makni F, Bouassida S, Ayadi A. Favus due to Trichophyton mentagrophytes var. quinckeanum. Mycoses. Sep 2003;46(8):358-60. [Medline].

  5. Garcia-Sanchez MS, Pereiro M Jr, Pereiro MM, Toribio J. Favus due to Trichophyton mentagrophytes var. quinckeanum. Dermatology. 1997;194(2):177-9. [Medline].

  6. Grappel SF, Blank F, Bishop CT. Circulating antibodies in human favus. Dermatologica. 1971;143(5):271-6. [Medline].

  7. Loveman AB, Kotcher E. Favus in Kentucky: diagnosis, treatment and epidemiology. J Ky Med Assoc. Jul 1962;60:643-55. [Medline].

  8. Pawlowicz A. Epidemiology of tinea capitis, particularly tinea favosa in the Poznan region. Postepy Dermatol (Poznan). 1996;13:347-400.

  9. Scott DB, Scott FP. Dermatophytoses in South Africa. Sabouraudia. Nov 1973;11(3):279-82. [Medline].

  10. Khan KA, Anwar AA. Study of 73 cases of tinea capitis and tinea favosa in adults and adolescents. J Invest Dermatol. Dec 1968;51(6):474-7. [Medline].

  11. Matte SM, Lopes JO, Melo IS, Beber AA. A focus of favus due to Trichophyton schoenleinii in Rio Grande do Sul, Brasil. Rev Inst Med Trop Sao Paulo. Jan-Feb 1997;39(1):1-3. [Medline].

  12. Prochnau A, de Almeida HL Jr, Souza PR, Vetoratto G, Duquia RP, Defferrari R. Scutular tinea of the scrotum: report of two cases. Mycoses. May 2005;48(3):162-4. [Medline].

  13. BLANK F. Human favus in Quebec. Dermatologica. 1962;125:369-81. [Medline].

  14. Joly J, Delage G, Auger P, Ricard P. Favus: twenty indigenous cases in the province of Quebec. Arch Dermatol. Nov 1978;114(11):1647-8. [Medline].

  15. Ilkit M. Favus of the scalp: an overview and update. Mycopathologia. Sep 2010;170(3):143-54. [Medline].

  16. García-Vargas A, Mayorga-Rodríguez JA, Sandoval-Tress C. Scalp demodicidosis mimicking favus in a 6-year-old boy. J Am Acad Dermato. 2007;57, suppl. 2:S19-S21.

  17. Kwasniewska J. Current antifungal agents in dermatology. Postepy Dermatol (Poznan). 1997;14:129-35.

  18. Baran E, Szepietowski J, Walow B. Fungal infections in the lower-Silesian region in the years 1974-1991. Part 1. Frequency of occurrence. Przegl Dermatol. 1992;79:294-301.

  19. Ceburkovas O, Schwartz RA, Janniger CK. Tinea capitis: current concepts. J Dermatol. Mar 2000;27(3):144-8. [Medline].

  20. Dvoretzky I, Fisher BK, Movshovitz M, Schewach-Millet M. Favus. Int J Dermatol. Mar 1980;19(2):89-92. [Medline].

  21. Macura AB. Resistance to antimycotic drugs. Postepy Dermatol (Poznan). 1997;14:137-40.

  22. Szepietowski J. Dermatomycoses and onychomycosis. A practical guide. Medycyna Praktyczna, Krakow. 2001.

 
Previous
Next
 
Tinea favosa of the scalp shows erythematous lesions with pityroid scaling. Some hairs are short and brittle.
Favus of the scalp shows extensive lesions with scarring alopecia.
Typical fluorescence under Wood lamp examination.
Favus, wax montage. Courtesy of Professor Dr Feliks Wasik, Dermatology, Medical University of Wroclaw, Poland.
Black man, aged 45 years, with favuslike yellow crusting of scalp. Potassium hydroxide and fungal culture were negative.
Culture of Trichophyton schoenleinii on Sabouraud agar. Courtesy of Anna Pawlowicz, PhD, and Professor Barbara Raszeja-Kotelba, MD, Dermatology, University School of Poznan, Poland.
Culture of Trichophyton schoenleinii on Sabouraud agar. Note pleomorphism of the culture. Courtesy of Anna Pawlowicz, PhD, and Professor Barbara Raszeja-Kotelba, MD, Dermatology, University School of Poznan, Poland.
Microculture of Trichophyton schoenleinii shows dichotomic branching and terminal swelling. Light-field microscopy, original magnification X 1000. Courtesy of Anna Pawlowicz, PhD, and Professor Barbara Raszeja-Kotelba, MD, Dermatology, University School of Poznan, Poland.
Microculture of Trichophyton schoenleinii shows characteristic dichotomic branching. Light-field microscopy, original magnification X 1000. Courtesy of Anna Pawlowicz, PhD, and Professor Barbara Raszeja-Kotelba, MD, Dermatology, University School of Poznan, Poland.
Microculture of Trichophyton schoenleinii shows numerous terminal chlamydospores. Light-field microscopy, original magnification X 1200. Courtesy of Anna Pawlowicz, PhD, and Professor Barbara Raszeja-Kotelba, MD, Dermatology, University School of Poznan, Poland.
Infected hair filled with hyphae shows bubbles of gas and gas tunnels (light field microscopy, original magnification X 2300).
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.